Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
16:22:34 EDT Mon 24 Mar 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

V:MDCX - Medicus Pharma Ltd. - https://medicuspharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MDCX - VDEFUNCT5.69    7.60  2.55Feb 21Mar 0615 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
        
        
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-03-06 20:31C:MDCX5.69News ReleaseMedicus Pharma Ltd. Announces Pricing of $4.2 Million Regulation A Offering
2025-03-06 07:31C:MDCX5.69News ReleaseMedicus Pharma Ltd Announces Positively Trending Interim Analysis for SKNJCT-003 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)
2025-02-27 07:32C:MDCX5.69News ReleaseMedicus Pharma Ltd Announces Submission of Phase 2 Clinical Design (SKNJCT-004) to United Arab Emirates (UAE) Department of Health (DOH) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)
2025-02-20 16:35C:MDCX5.70Shares Delisted from TSX-VMedicus Pharma to be delisted from TSX-V
2025-02-14 14:32C:MDCX3.90News ReleaseMedicus randomizes 50% of patients for SKNJCT-003 study
2025-02-11 17:32C:MDCX3.85News ReleaseMedicus Pharma to delist from TSX-V, enters SEPA
2024-12-18 16:42C:MDCX3.95Private PlacementMedicus Pharma 970,000-share private placement
2024-12-12 16:05C:MDCX3.95News ReleaseMedicus's D-MNA receives MUMS designation from FDA
2024-12-02 18:25C:MDCX3.60News ReleaseMedicus to expand phase 2 study of basal cell carcinoma
2024-11-22 21:18C:MDCX3.07SEDAR Interim MD & ASEDAR Interim MD & A
2024-11-22 21:12C:MDCX3.07SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-11-18 16:10C:MDCX2.90News ReleaseMedicus appoints Mehmud as chief medical officer
2024-11-15 16:59C:MDCX2.90News ReleaseMedicus closes $4M (U.S.) initial public offering
2024-11-13 18:55C:MDCX6.49News ReleaseMedicus prices U.S. IPO at $4.125 (U.S.) per unit
2024-10-28 13:51C:MDCX3.49News ReleaseMedicus Pharma completes 1:2 share rollback
2024-10-28 13:12C:MDCX3.49News ReleaseCanadian Investment Regulatory Organization Trade Resumption - MDCX
2024-10-28 12:36C:MDCX3.49Resume TradingMedicus Pharma to resume at 10 a.m. PT
2024-10-25 08:07C:MDCX3.49News ReleaseCanadian Investment Regulatory Organization Trading Halt - MDCX
2024-10-25 07:59C:MDCX3.49Halt TradingMedicus Pharma halted at the open
2024-10-24 18:54C:MDCX3.49RollbackMedicus Pharma 1:2 rollback